India Pesticides Ltd Schedules Q1 FY27 Earnings Call for August 13

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

India Pesticides Limited has scheduled a Q1 FY27 earnings conference call for August 13, 2026, at 12:30 PM IST, to discuss unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The call will be led by CEO D. K. Jain and CFO S. P. Gupta, with the intimation issued on August 3, 2026, by Company Secretary Narendra Ojha, in compliance with SEBI listing regulations.

powered bylight_fuzz_icon
47304200

*this image is generated using AI for illustrative purposes only.

India Pesticides Limited will host an earnings conference call on Thursday, August 13, 2026, at 12:30 PM IST to discuss its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The event provides investors and analysts an opportunity to review the company's performance in Q1 FY27 and address queries regarding operational and financial metrics. This disclosure is made pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The conference call will be led by senior management, including D. K. Jain, Chief Executive Officer, and S. P. Gupta, Chief Financial Officer. Participants can join via a DiamondPass registration link or through universal access dial-in numbers provided by the company. International participants may use toll-free numbers available for Hong Kong, Singapore, the USA, and the UK. Pre-registration is recommended to avoid waiting queues during the live session.

Conference Call Details

The key details of the upcoming earnings call are summarised below:

Parameter: Details
Date: August 13, 2026
Time: 12:30 PM IST
Quarter: Q1 FY27 (ended June 30, 2026)
Format: Conference Call with Analysts/Investors
Key Speakers: D. K. Jain (CEO), S. P. Gupta (CFO)

Investors are advised to register in advance using the provided link to ensure seamless access to the call. The company has also made the relevant information available on its official website for public reference. This proactive communication aims to maintain transparency and keep stakeholders informed about the company's financial health and strategic direction.

Regulatory Compliance

The intimation was issued on August 3, 2026, and signed by Narendra Ojha, Company Secretary and Compliance Officer. The notice was submitted to both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India Ltd. (NSE), ensuring compliance with listing obligations.

For further information or research support, investors may contact Viral Shah, VP Research, or Nitin Raheja, Research Associate, at Dolat Capital Market Private Limited. Their contact details have been shared for any additional queries related to the earnings discussion or market analysis.

Historical Stock Returns for India Pesticides

1 Day5 Days1 Month6 Months1 Year5 Years
+1.01%-1.21%-10.32%-12.17%-34.55%-56.56%

How might India Pesticides Limited's Q1 FY27 performance influence its valuation multiples relative to other agrochemical peers in the Indian market?

What strategic initiatives or capex plans is management likely to highlight to justify future growth trajectories beyond the current quarter?

Could the unaudited financial results signal any shifts in raw material cost pressures or margin trends for the broader agrochemical sector in FY27?

India Pesticides Q1FY27 profit falls 34% on Pretilachlor demand slump

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

India Pesticides Limited's Q1FY27 net profit fell 34.3% to ₹23 crore due to weaker domestic demand for Pretilachlor and higher operational costs. Export sales remained stable at ₹89 crore, while job work charges rose to ₹14 crore. The company received EU TEQ approval for a fungicide product.

powered bylight_fuzz_icon
47202629

*this image is generated using AI for illustrative purposes only.

India Pesticides Limited reported a 34.3% year-on-year decline in standalone net profit after tax (PAT) to ₹23 crore for the quarter ended June 30, 2026, reflecting persistent headwinds in the domestic agrochemical sector. The decline was primarily driven by an 8.6% drop in revenue from operations to ₹252.56 crore from ₹275.41 crore in the corresponding period of FY26, attributed to softer domestic demand for its flagship herbicide, Pretilachlor, and increased operational costs including job work processing charges and fuel expenses.

The unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on August 1, 2026. The results were subsequently reviewed by Statutory Auditors and filed with the stock exchanges pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also published extracts of the results in Financial Express (English) and Jansatta (Hindi) on August 2, 2026.

Financial Performance Overview

Metric Standalone Q1FY27 (₹ Cr) Standalone Q1FY26 (₹ Cr) YoY Change (%)
Revenue from Operations 252.56 275.41 (8.6%)
Profit Before Tax 31.39 47.62 (34.1%)
Net Profit After Tax 23.07 35.38 (34.8%)
EPS (Basic, ₹) 1.98 3.03 (34.7%)

Consolidated total income from operations stood at ₹251.76 crore, down from ₹275.18 crore in Q1FY26. The consolidated profit before tax was ₹30.85 crore, compared to ₹47.08 crore in the previous year. Earnings per share (basic and diluted) remained consistent at ₹1.98 for both standalone and consolidated figures.

Operational Pressures and Strategic Outlook

The divergence between gross profit stability and bottom-line contraction highlights rising operating leverage pressures. While gross margins have been maintained at healthy levels, downstream manufacturing costs, particularly job work processing charges which jumped to ₹14 crore from ₹8 crore year-on-year, eroded profitability. Export sales showed resilience, increasing marginally to ₹89 crore from ₹87 crore in Q1FY26, supported by stable international demand across 35+ countries, but this growth was insufficient to offset the domestic slowdown.

Dheeraj Kumar Jain, Chief Executive Officer, noted that elevated channel inventory and higher fuel costs further strained profitability in the quarter. Despite near-term pressures, management emphasized a focus on operational efficiency and cost management. A key strategic milestone highlighted was the receipt of Technical Equivalence (TEQ) approval from the European Union for a fungicide product, strengthening the company’s position in international markets.

Capacity Expansion and Market Position

India Pesticides Limited continues to leverage its manufacturing capabilities across two primary facilities in Sandila, Hardoi, and Dewa Road, Lucknow, with a combined permitted capacity of 28,200 MT for technicals and 10,000 MT for formulations. A new facility in Hamirpur is under development; two out of ten operating blocks are currently functional for insecticides and herbicides. Two additional blocks are expected to become operational in FY27, contributing to a total permitted capacity expansion of 30,000 MT for technicals and 6,000 MT for formulations.

Revenue concentration remains a focus area, with top 10 customers accounting for 51% of revenue in Q1FY27, up from 40% in FY26. The company is actively reducing dependency on imported intermediates, particularly from China, through in-house R&D and project engineering capabilities, aiming to improve cost efficiencies while sustaining HSE and ESG standards.

Historical Stock Returns for India Pesticides

1 Day5 Days1 Month6 Months1 Year5 Years
+1.01%-1.21%-10.32%-12.17%-34.55%-56.56%

How will the phased commissioning of the Hamirpur facility in FY27 impact India Pesticides Limited's cost structure and ability to offset rising job work processing charges?

What is the expected timeline for the EU-approved fungicide product to contribute meaningfully to export revenue, and how might this diversify the company's product portfolio beyond Pretilachlor?

Given the 51% revenue concentration among top customers, what specific strategies is management deploying to mitigate counterparty risk and broaden its domestic customer base?

More News on India Pesticides

1 Year Returns:-34.55%